An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 07 Nov 2016
At a glance
- Drugs Abatacept (Primary)
- Indications Alopecia areata
- Focus Therapeutic Use
- 27 Oct 2016 Planned End Date changed from 1 Jul 2016 to 1 Jul 2017.
- 27 Oct 2016 Planned primary completion date changed from 1 Jul 2016 to 1 Jul 2017.
- 08 Jan 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.